アジア太平洋バイオプロセス市場予測 2031年 - 地域別分析 - 製品別(機器および消耗品・付属品)、事業規模別(商業事業および臨床事業)、プロセス別(下流バイオプロセスおよび上流バイオプロセス)、用途別(モノクローナル抗体、ワクチン、組み換えタンパク質、細胞・遺伝子治療など)、エンドユーザー別(バイオ医薬品会社、契約製造組織など)

BMIRE00030823 | Pages: 168 | Biotechnology | Oct 2024 | Type: Regional | Status: Published
アジア太平洋地域のバイオプロセス市場は、2023年に54億8,887万米ドルと評価され、2031年までに168億6,877万米ドルに達すると予想されています。また、2023年から2031年にかけて15.1%のCAGRを記録すると予測されています。

パーソナライズ医療の需要の高まりがアジア太平洋地域のバイオプロセス市場を後押し

ヘルスケア業界が画一的なアプローチからターゲットを絞ったアプローチへと変革したことで、パーソナライズ医療の需要が拡大しています。精密医療は、がん、神経変性疾患、希少遺伝性疾患などの健康問題に取り組む最も有望なアプローチの1つと考えられています。パーソナライズ医療の生産におけるイノベーションは、業界全体に影響を及ぼす可能性があり、小容量生産を目的としたシングルユース技術は、特に下流プロセスにおけるタンパク質バイオ生産に潜在的な用途があります。医療に対する個別化および差別化アプローチにより、より幅広い製品の必要性が生じています。その多くは比較的少数の患者を対象としています。したがって、生物学的製剤の製造と提供に対する根本的に異なるアプローチが必要になる場合があります。精密医療は、個人のゲノム情報を利用して、特定の適応症に対する標的治療を提供します。希少疾患の増加により、生物製剤と医薬品の需要が高まり、その結果、個別化医療の成長が促進されました。2019年、FDAは、疾患の根本原因に対処するための約12の個別化医薬品を承認し、臨床ケアと精密医療をさらに統合しました。また、政府の取り組みの増加により、個別化医療の研究活動が強化されています。たとえば、2020年2月、国立ヒトゲノム研究所(NHGRI)は、新しい精密医療およびゲノミクスプログラムを設立すると発表しました。このプログラムは、疾患のより良い診断と治療のためのゲノミクスおよびインフォマティクスツールの革新に重点を置いています。個別化医療は、遺伝学とバイオインフォマティクスの進歩を活用して、特定の患者集団をターゲットにし、これまで治療できなかった疾患を治療します。パーソナライズ医療では、バイオプロセス技術を使用してカスタマイズされた治療法を開発します。特定の細胞の分離から患者固有の治療法の開発まで、バイオプロセスの手順は、各患者に合わせた治療法を生み出すために不可欠です。したがって、パーソナライズ医療の需要の高まりは、予測期間中にバイオプロセス市場で活動するプレーヤーに大きな成長の機会を提供すると予測されています。

アジア太平洋バイオプロセス市場の概要

アジア太平洋バイオプロセス市場は、中国、日本、インド、韓国、オーストラリア、およびその他のアジア太平洋地域に分割されています。これらの国での市場の成長は、慢性疾患の有病率の上昇と有利な償還ポリシーに起因しています。さらに、市場プレーヤーが実施する拡張および製品発売戦略は、この地域のバイオプロセス技術市場の成長に貢献すると予想されます。中国は2023年に市場で最大のシェアを占め、インドは予測期間中に市場で大幅なCAGRを記録すると予想されています。中国のバイオ医薬品業界は、ジェネリック中心の環境から活気のあるイノベーションハブへと進化し、大きな変化を遂げています。さらに、工業化の進歩と新薬、ハイエンドの医療機器、技術の応用は、中国のバイオプロセス市場の成長に貢献しています。したがって、研究センターの数の増加、政府の資金の増加、および地理的拡大のための市場プレーヤーによる絶え間ない取り組みは、アジア太平洋地域のバイオプロセス市場の成長を促進します。

アジア太平洋地域のバイオプロセス市場の収益と2031年までの予測(百万米ドル)

アジア太平洋地域のバイオプロセス市場のセグメンテーション

アジア太平洋地域のバイオプロセス市場は、製品、運用規模、プロセス、アプリケーション、エンドユーザー、および国に分類されます。

製品に基づいて、アジア太平洋地域のバイオプロセス市場は、機器と消耗品とアクセサリに分かれています。 機器セグメントは、2023年に大きな市場シェアを占めました。さらに、機器セグメントは、ろ過装置、バイオリアクター、クロマトグラフィーシステム、遠心分離機、乾燥装置などに細分化されています。さらに、バイオリアクターのサブセグメントは、パイロットスケール、フルスケール、およびラボスケールに分類されます。さらに、サブセグメントのクロマトグラフィーシステムは、液体クロマトグラフィー、ガスクロマトグラフィー、およびその他のセグメントに分割されます。さらに、消耗品およびアクセサリセグメントは、試薬、細胞培養培地、クロマトグラフィー樹脂、およびその他のセグメントにサブセグメント化されます。

運用規模では、アジア太平洋地域のバイオプロセス市場は商業運用と臨床運用に分かれています。商業運用セグメントは、2023年に大きな市場シェアを占めました。

プロセス別では、アジア太平洋地域のバイオプロセス市場は、下流バイオプロセスと上流バイオプロセスに分かれています。下流バイオプロセスセグメントは、2023年に大きな市場シェアを占めました。

アプリケーションに基づいて、アジア太平洋地域のバイオプロセス市場は、モノクローナル抗体、ワクチン、組み換えタンパク質、細胞および遺伝子治療などに分類されます。モノクローナル抗体セグメントは、2023年に最大の市場シェアを占めました。

エンドユーザーの観点から、アジア太平洋地域のバイオプロセシング市場は、バイオ医薬品会社、契約製造組織、その他に分類されます。バイオ医薬品会社セグメントは、2023年に最大の市場シェアを占めました。

国別に見ると、アジア太平洋地域のバイオプロセシング市場は、中国、インド、日本、韓国、オーストラリア、その他のアジア太平洋地域に分かれています。2023年には、中国がアジア太平洋地域のバイオプロセシング市場シェアを独占しました。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc、Cytiva US LLCは、アジア太平洋地域のバイオプロセシング市場で事業を展開している大手企業の一部です。

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Bioprocessing Market Landscape

4.1 Ecosystem Analysis

4.1.1 List of Vendors in the Value Chain

5. Asia Pacific Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Growing Biopharmaceutical Industry

5.2 Market Restraints

5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing

5.3 Market Opportunities

5.3.1 Proliferating Demand for Personalized Medicine

5.4 Future Trends

5.4.1 Shift Toward Automated Cell Therapy Manufacturing

5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Asia Pacific Analysis

6.1 Asia Pacific Bioprocessing Market Overview

6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Asia Pacific Bioprocessing Market Analysis - by Product

7.1 Overview

7.2 Instruments

7.2.1 Overview

7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

7.3 Consumables & Accessories

7.3.1 Overview

7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview

8.2 Commercial Operations

8.2.1 Overview

8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Clinical Operations

8.3.1 Overview

8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Bioprocessing Market Analysis - by Process

9.1 Overview

9.2 Downstream Bioprocess

9.2.1 Overview

9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Upstream Bioprocess

9.3.1 Overview

9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Bioprocessing Market Analysis - by Application

10.1 Overview

10.2 Monoclonal Antibodies

10.2.1 Overview

10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Vaccines

10.3.1 Overview

10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Recombinant Protein

10.4.1 Overview

10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.5 Cell & Gene Therapy

10.5.1 Overview

10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Bioprocessing Market Analysis - by End User

11.1 Overview

11.2 Biopharmaceutical Companies

11.2.1 Overview

11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Contract Manufacturing Organization

11.3.1 Overview

11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.4 Others

11.4.1 Overview

11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Bioprocessing Market - Country Analysis

12.1 Asia Pacific

12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.1.1 Overview

12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product

12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments

12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process

12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application

12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User

12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.3.1 Overview

12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product

12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments

12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process

12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application

12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User

12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.5.1 Overview

12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product

12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments

12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process

12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application

12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User

12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.7.1 Overview

12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product

12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments

12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process

12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application

12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User

12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.9.1 Overview

12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product

12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments

12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process

12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application

12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User

12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.11.1 Overview

12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product

12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments

12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process

12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application

12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Bioprocessing Market

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Getinge AB

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Thermo Fisher Scientific Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sartorius AG

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Corning Inc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bio-Rad Laboratories Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Merck KGaA

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 3M Co

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Eppendorf SE

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Repligen Corp

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Entegris Inc

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Agilent Technologies Inc

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Cytiva US LLC

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Asia Pacific Bioprocessing Market Segmentation

Table 2. List of Vendors

Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market

Table 62. Recent Organic Growth Strategies in the Bioprocessing Market

Table 63. Glossary of Terms, Bioprocessing Market

 

?

List of Figures

Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country

Figure 2. Bioprocessing Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031

Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)

Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)

Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)

Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)

Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)

Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)

Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 32. Growth Strategies in the Bioprocessing Market

  1. Getinge AB
  2. Thermo Fisher Scientific Inc
  3. Sartorius AG
  4. Corning Inc
  5. Bio-Rad Laboratories Inc
  6. Merck KGaA
  7. 3M Co
  8. Eppendorf SE
  9. Repligen Corp
  10. Entegris Inc
  11. Agilent Technologies Inc
  12. Cytiva US LLC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioprocessing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440